Wednesday, November 17, 2010

personal finance programs

The college preparatory schools would be restructured to teach by modules (the vocational schools could be similarly designed). For each grade level, a curriculum would be established identifying the subjects to be mastered to complete that grade. These might include fifteen to twenty topics each for math, science, history, language arts, fine arts, etc. Students would choose a topic module (e.g., beginning algebra: how to solve an equation), attend the classes, take a test (which might be written or oral), and have that module signed off by the teacher. Modules may be taken in any order, and students need not attend class to have a skill signed off; that is, they may study on their own or test on prior experience. Once all requirements for a grade were completed, the student would be awarded a diploma for that grade. Students would no longer achieve "high school graduation," but would be a graduate of the grade completed with a diploma for each level of achievement. Dropouts would no longer exist because every student would be a diploma-holding graduate of the last grade he/she completed successfully. Ronald D. Sugar Joins Apple's Board of Directors



CUPERTINO, Calif.--(BUSINESS WIRE)--Apple® today announced that Dr. Ronald D. Sugar, former Chairman of the Board and CEO of Northrop Grumman Corporation, was appointed to Apple's Board of Directors. Dr. Sugar will serve as the Chair of the Audit and Finance Committee.



"Ron is an engineer at heart, who then became a very successful business leader. We are very excited to welcome him to Apple's Board"



"Ron is an engineer at heart, who then became a very successful business leader. We are very excited to welcome him to Apple's Board," said Steve Jobs, Apple's CEO. "In addition to having been the CEO of a high-tech Fortune 100 company, Ron has a Ph.D. in engineering and has been involved in the development of some very sophisticated technology."



"I have always had enormous admiration for the people of Apple," said Sugar. "It is a special privilege to serve on the board of such an amazing company."



Dr. Sugar served as Chairman and Chief Executive Officer at Northrop Grumman Corporation from 2003 until his retirement in 2010. Previous to Northrop, he held executive positions at Litton Industries and TRW Inc., where he served as chief financial officer.



He is a member of the National Academy of Engineering and a fellow of both the American Institute of Aeronautics and Astronautics and the Royal Aeronautical Society. He is a director of Chevron Corporation, Amgen Inc. and Air Lease Corporation, and serves as a senior advisor to the private investment firm Ares Management LLC.



He is a trustee of the University of Southern California, where he also holds the Judge Widney Chair as Professor of Management and Technology. He is a member of the boards of UCLA Anderson School of Management, the Los Angeles Philharmonic Orchestra and several other philanthropic organizations focused on children and education.



He graduated summa cum laude in engineering in 1968 from the University of California, Los Angeles, where he also received master's and doctorate degrees in the same field. He subsequently completed executive programs at Stanford, Wharton and Harvard.



Apple designs Macs, the best personal computers in the world, along with OS X, iLife, iWork, and professional software. Apple leads the digital music revolution with its iPods and iTunes online store. Apple is reinventing the mobile phone with its revolutionary iPhone and App Store, and has recently introduced its magical iPad which is defining the future of mobile media and computing devices.



NOTE TO EDITORS: For additional information visit Apple's PR website (www.apple.com/pr), or call Apple's Media Helpline at (408) 974-2042.



© 2010 Apple Inc. All rights reserved. Apple, the Apple logo, Mac, Mac OS and Macintosh are trademarks of Apple. Other company and product names may be trademarks of their respective owners.
alpine payment systems scam

More Bad <b>News</b> for Obama 2012: Catholics Elect Dolan - Swampland <b>...</b>

Corrected Nov. 17: The Catholic bishops' surprise election yesterday of New York's Archbishop Timothy M. Dolan as their president is more bad news for Obama in 2012.

Pharmaceutical <b>News</b> Roundup: Human Genome&#39;s Lupus Drug, Merck&#39;s <b>...</b>

Here's a roundup of some of Wednesday's major pharmaceutical news: An FDA panel gave Human Genome Sciences a boost with a thumbs-up for its lupus drug, Benlysta; Merck's experimental heart drug appears to work well without side effects; ...

<b>News</b> Corp. iPad Venture Fishing In Wrong Pond | paidContent

Another day, another hire at News Corp.'s super-duper secret iPad venture dubbed The Daily—and another reason to question whether this is going to be yet another wobbly Rupert Murdoch digital-news enterprise. ...



10di1227-52 by USDAgov


More Bad <b>News</b> for Obama 2012: Catholics Elect Dolan - Swampland <b>...</b>

Corrected Nov. 17: The Catholic bishops' surprise election yesterday of New York's Archbishop Timothy M. Dolan as their president is more bad news for Obama in 2012.

Pharmaceutical <b>News</b> Roundup: Human Genome&#39;s Lupus Drug, Merck&#39;s <b>...</b>

Here's a roundup of some of Wednesday's major pharmaceutical news: An FDA panel gave Human Genome Sciences a boost with a thumbs-up for its lupus drug, Benlysta; Merck's experimental heart drug appears to work well without side effects; ...

<b>News</b> Corp. iPad Venture Fishing In Wrong Pond | paidContent

Another day, another hire at News Corp.'s super-duper secret iPad venture dubbed The Daily—and another reason to question whether this is going to be yet another wobbly Rupert Murdoch digital-news enterprise. ...


alpine payment systems scam

More Bad <b>News</b> for Obama 2012: Catholics Elect Dolan - Swampland <b>...</b>

Corrected Nov. 17: The Catholic bishops' surprise election yesterday of New York's Archbishop Timothy M. Dolan as their president is more bad news for Obama in 2012.

Pharmaceutical <b>News</b> Roundup: Human Genome&#39;s Lupus Drug, Merck&#39;s <b>...</b>

Here's a roundup of some of Wednesday's major pharmaceutical news: An FDA panel gave Human Genome Sciences a boost with a thumbs-up for its lupus drug, Benlysta; Merck's experimental heart drug appears to work well without side effects; ...

<b>News</b> Corp. iPad Venture Fishing In Wrong Pond | paidContent

Another day, another hire at News Corp.'s super-duper secret iPad venture dubbed The Daily—and another reason to question whether this is going to be yet another wobbly Rupert Murdoch digital-news enterprise. ...


No comments:

Post a Comment